Prior authorization is a barrier to accessing medications for opioid use disorder (MOUD). Although private insurance covered about one-third of patients with OUD in 2023, the understanding of prior ...

Under the Consolidated Appropriations Act, 2023, which required the provision of national twelve-month continuous Medicaid eligibility for children up to age nineteen, children’s Medicaid enrollment ...

In any review of mifepristone, the FDA will now have to grapple with Judge Otake’s conclusion that the 2023 REMS decision for ...

Without policy intervention to address average sales price-based challenges to biosimilar market sustainability, there is a ...

US v. Skrmetti undermined constitutional guardrails that guarantee rigorous assessment of medical justifications for policies limiting the rights of transgender people and women, creating a need and ...

The No Surprises Act has protected patients from surprise medical bills. However, the law’s incentives for insurers acting as ...

There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...

Health Affairs' Jeff Byers welcomes Allison Oakes, Chief Research Officer of Trilliant Health, to the pod to discuss ...

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...

While recent fertility drug-related announcements by the Trump administration could result in savings for women—especially ...

Adopting the proper countermeasures to protect and maintain trust in health care data will require additional collaboration ...

When the Narcan didn’t work I ran to the shelter to ask for help.” We put an oxygen mask on the patient and used a bag-valve-mask device to breathe for him. His color returned, and very shortly after ...